Darryl Steensma is counsel in the San Diego office of Latham & Watkins and a member of the firm’s Technology Transactions and Intellectual Property Practices. Dr. Steensma’s practice focuses on representing companies in the biotechnology, pharmaceutical, medical device and diagnostics industries in a range of intellectual property-based transactions. He advises such clients in matters regarding:
- Complex licensing transactions
- Co-promotion, co-marketing and co-commercialization agreements
- University license agreements
- Distribution agreements
- Research and collaboration agreements
- Asset purchases and mergers
- Manufacturing and quality agreements
Dr. Steensma also represents various buyers, sellers, investment banks and other financial institutions in performing business, scientific and intellectual property due diligence for private and public financings and mergers and acquisitions of life science companies.
Dr. Steensma is registered to practice before the United States Patent and Trademark Office, and provides advice and counsel to clients regarding US and foreign patent prosecution in the biotechnology, pharmaceutical, medical device and diagnostic industries. He frequently counsels clients regarding current and future patent portfolio strategies. He also represents multinational and start-up companies in pharmaceutical and life sciences litigation, including substantial representation in Hatch-Waxman litigation, and advises clients on regulatory exclusivities and preparing citizen petitions to the FDA. He is admitted to practice before numerous trial and appellate courts including the United States Supreme Court, the Court of Appeals for the Federal Circuit and the Ninth Circuit, the District Courts for the Central and Southern Districts of California and the California Supreme Court.
Prior to attending law school, Dr. Steensma held postdoctoral research positions at The Scripps Research Institute and at Georgetown University Medical Center. While in law school, he served as a Scientific Advisor to an intellectual property law firm in New York City. He is a named co-inventor on four US patents and is a co-author of over 10 peer-reviewed research publications.
Dr. Steensma is a member of the American Chemical Society, the AIPLA Biotechnology Committee, the BIOCOM Intellectual Property Committee, the San Diego Intellectual Property Law Association and the Louis M. Welsh Inn of Court.